Type-2 Diabetes and Blood Sugar Disorders References

  1. Freeman AM, Pennings N. Insulin Resistance. [Updated 2021 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan
  2. Taylor R. Insulin resistance and type 2 diabetes. Diabetes. 2012 Apr;61(4):778-9. doi: 10.2337/db12-0073. PMID: 22442298; PMCID: PMC3314346.
  3. Mechanick JI, Garber AJ, Grunberger G, Handelsman Y, Garvey WT. DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENT. Endocr Pract. 2018 Nov;24(11):995-1011. doi: 10.4158/PS-2018-0139. PMID: 30763128.
  4. https://www.healio.com/news/endocrinology/20181128/position-statement-identifies-4-distinct-stages-of-type-2-diabetes
  5. Fahed M, Abou Jaoudeh MG, Merhi S, Mosleh JMB, Ghadieh R, Al Hayek S, El Hayek Fares JE. Evaluation of risk factors for insulin resistance: a cross sectional study among employees at a private university in Lebanon. BMC Endocr Disord. 2020 Jun 10;20(1):85. doi: 10.1186/s12902-020-00558-9. PMID: 32522257; PMCID: PMC7288486.
  6. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance.
  7. https://www.cdc.gov/diabetes/basics/type2.html
  8. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10. PMID: 31518657.
  9. American Diabetes Association Professional Practice Committee; American Diabetes Association Professional Practice Committee:, Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M. 13. Older Adults: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Supplement_1):S195-S207. doi: 10.2337/dc22-S013. PMID: 34964847.
  10. Bădescu SV, Tătaru C, Kobylinska L, Georgescu EL, Zahiu DM, Zăgrean AM, Zăgrean L. The association between Diabetes mellitus and Depression. J Med Life. 2016 Apr-Jun;9(2):120-5. PMID: 27453739; PMCID: PMC4863499.
  11. Hamer JA, Testani D, Mansur RB, Lee Y, Subramaniapillai M, McIntyre RS. Brain insulin resistance: A treatment target for cognitive impairment and anhedonia in depression. Exp Neurol. 2019 May;315:1-8. doi: 10.1016/j.expneurol.2019.01.016. Epub 2019 Jan 26. PMID: 30695707.
  12. Watson KT, Simard JF, Henderson VW, Nutkiewicz L, Lamers F, Nasca C, Rasgon N, Penninx BWJH. Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study. Am J Psychiatry. 2021 Oct 1;178(10):914-920. doi: 10.1176/appi.ajp.2021.20101479. Epub 2021 Sep 23. PMID: 34551583.
  13. Lyra E Silva NM, Lam MP, Soares CN, Munoz DP, Milev R, De Felice FG. Insulin Resistance as a Shared Pathogenic Mechanism Between Depression and Type 2 Diabetes. Front Psychiatry. 2019 Feb 14;10:57. doi: 10.3389/fpsyt.2019.00057. PMID: 30837902; PMCID: PMC6382695.
  14. Calkin CV. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder. Ann Med. 2019 Aug-Sep;51(5-6):281-293. doi: 10.1080/07853890.2019.1659511. Epub 2019 Aug 27. PMID: 31453713; PMCID: PMC7877881.
  15. de la Monte SM, Wands JR. Alzheimer’s disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol. 2008 Nov;2(6):1101-13. doi: 10.1177/193229680800200619. PMID: 19885299; PMCID: PMC2769828.
  16. Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau VV. Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease. Int J Mol Sci. 2020 Apr 30;21(9):3165. doi: 10.3390/ijms21093165. PMID: 32365816; PMCID: PMC7246646.
  17. Wei Z, Koya J, Reznik SE. Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms. Front Neurosci. 2021 Jul 19;15:687157. doi: 10.3389/fnins.2021.687157. PMID: 34349617; PMCID: PMC8326507.
  18. Pardeshi R, Bolshette N, Gadhave K, Ahire A, Ahmed S, Cassano T, Gupta VB, Lahkar M. Insulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease. Psychoneuroendocrinology. 2017 Sep;83:159-171. doi: 10.1016/j.psyneuen.2017.05.004. Epub 2017 May 30. PMID: 28624654.
  19.  https://www.alz.org/aaic/releases_2021/covid-19-cognitive-impact.asp
  20. Shauly-Aharonov M, Shafrir A, Paltiel O, Calderon-Margalit R, Safadi R, Bicher R, Barenholz-Goultschin O, Stokar J. Both high and low pre-infection glucose levels associated with increased risk for severe COVID-19: New insights from a population-based study. PLoS One. 2021 Jul 22;16(7):e0254847. doi: 10.1371/journal.pone.0254847. PMID: 34293038; PMCID: PMC8297851.
  21. Gangadharan C, Ahluwalia R, Sigamani A. Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity. World J Diabetes. 2021 Sep 15;12(9):1550-1562. doi: 10.4239/wjd.v12.i9.1550. PMID: 34630907; PMCID: PMC8472493.
  22. Su et al., Multiple early factors anticipate post-acute COVID-19 sequelae, Cell (2022), https://doi.org/10.1016/j.cell.2022.01.014
  23. https://www.diabetes.org/healthy-living/medication-treatments/insulin-resistance#:~:text=No%20medications%20are%20specifically%20approved,part%2C%20by%20reducing%20insulin%20resistance.
  24. American Diabetes Association Professional Practice Committee; American Diabetes Association Professional Practice Committee:, Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022 Jan 1;45(Supplement_1):S125-S143. doi: 10.2337/dc22-S009. PMID: 34964831.
  25. Papalou O, Kandaraki EA, Papadakis G, Diamanti-Kandarakis E. Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease. Front Endocrinol (Lausanne). 2019 Mar 1;10:112. doi: 10.3389/fendo.2019.00112. PMID: 30881345; PMCID: PMC6406073.
  26. Pizzorno J. Is the Diabetes Epidemic Primarily Due to Toxins? Integr Med (Encinitas). 2016 Aug;15(4):8-17. PMID: 27574488; PMCID: PMC4991654.
  27. Heindel JJ, Vom Saal FS, Blumberg B, Bovolin P, Calamandrei G, Ceresini G, Cohn BA, Fabbri E, Gioiosa L, Kassotis C, Legler J, La Merrill M, Rizzir L, Machtinger R, Mantovani A, Mendez MA, Montanini L, Molteni L, Nagel SC, Parmigiani S, Panzica G, Paterlini S, Pomatto V, Ruzzin J, Sartor G, Schug TT, Street ME, Suvorov A, Volpi R, Zoeller RT, Palanza P. Parma consensus statement on metabolic disruptors. Environ Health. 2015 Jun 20;14:54. doi: 10.1186/s12940-015-0042-7. Erratum in: Environ Health. 2017 Dec 6;16(1):130. PMID: 26092037; PMCID: PMC4473834.
  28. Swedenborg E, Rüegg J, Mäkelä S, Pongratz I. Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders. J Mol Endocrinol. 2009 Jul;43(1):1-10. doi: 10.1677/JME-08-0132. Epub 2009 Feb 11. PMID: 19211731.
  29. Turk Wensveen T, Gašparini D, Rahelić D, Wensveen FM. Type 2 diabetes and viral infection; cause and effect of disease. Diabetes Res Clin Pract. 2021 Feb;172:108637. doi: 10.1016/j.diabres.2020.108637. Epub 2021 Jan 13. PMID: 33352263; PMCID: PMC8050380.
  30. Chakraborty S, Bhattacharyya R, Banerjee D. Infections: A Possible Risk Factor for Type 2 Diabetes. Adv Clin Chem. 2017;80:227-251. doi: 10.1016/bs.acc.2016.11.004. Epub 2017 Jan 3. PMID: 28431641.
  31. Caricilli AM, Saad MJ. The role of gut microbiota on insulin resistance. Nutrients. 2013 Mar 12;5(3):829-51. doi: 10.3390/nu5030829. PMID: 23482058; PMCID: PMC3705322.
  32. He FF, Li YM. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020 Jun 17;13(1):73. doi: 10.1186/s13048-020-00670-3. PMID: 32552864; PMCID: PMC7301991.
  33. Khan MT, Nieuwdorp M, Bäckhed F. Microbial modulation of insulin sensitivity. Cell Metab. 2014 Nov 4;20(5):753-760. doi: 10.1016/j.cmet.2014.07.006. PMID: 25176147.
  34. De Bandt JP, Waligora-Dupriet AJ, Butel MJ. Intestinal microbiota in inflammation and insulin resistance: relevance to humans. Curr Opin Clin Nutr Metab Care. 2011 Jul;14(4):334-40. doi: 10.1097/MCO.0b013e328347924a. PMID: 21587065.
  35. Mkumbuzi L, Mfengu MMO, Engwa GA, Sewani-Rusike CR. Insulin Resistance is Associated with Gut Permeability Without the Direct Influence of Obesity in Young Adults. Diabetes Metab Syndr Obes. 2020 Aug 24;13:2997-3008. doi: 10.2147/DMSO.S256864. PMID: 32922055; PMCID: PMC7457818.
  36. Cheng H, Gang X, He G, Liu Y, Wang Y, Zhao X, Wang G. The Molecular Mechanisms Underlying Mitochondria-Associated Endoplasmic Reticulum Membrane-Induced Insulin Resistance. Front Endocrinol (Lausanne). 2020 Nov 23;11:592129. doi: 10.3389/fendo.2020.592129. PMID: 33329397; PMCID: PMC7719781.
  37. Sangwung P, Petersen KF, Shulman GI, Knowles JW. Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications. Endocrinology. 2020 Apr 1;161(4):bqaa017. doi: 10.1210/endocr/bqaa017. PMID: 32060542; PMCID: PMC7341556.
  38. Sergi D, Naumovski N, Heilbronn LK, Abeywardena M, O’Callaghan N, Lionetti L, Luscombe-Marsh N. Mitochondrial (Dys)function and Insulin Resistance: From Pathophysiological Molecular Mechanisms to the Impact of Diet. Front Physiol. 2019 May 3;10:532. doi: 10.3389/fphys.2019.00532. PMID: 31130874; PMCID: PMC6510277.
  39. Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008 Feb 29;102(4):401-14. doi: 10.1161/CIRCRESAHA.107.165472. PMID: 18309108; PMCID: PMC2963150.
  40. Chen L, Chen R, Wang H, Liang F. Mechanisms Linking Inflammation to Insulin Resistance. Int J Endocrinol. 2015;2015:508409. doi: 10.1155/2015/508409. Epub 2015 Jun 2. PMID: 26136779; PMCID: PMC4468292.
  41. Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016 Dec 3;23(1):87. doi: 10.1186/s12929-016-0303-y. PMID: 27912756; PMCID: PMC5135788.
  42. Hurrle S, Hsu WH. The etiology of oxidative stress in insulin resistance. Biomed J. 2017 Oct;40(5):257-262. doi: 10.1016/j.bj.2017.06.007. Epub 2017 Nov 8. PMID: 29179880; PMCID: PMC6138814.